RESUMO
PURPOSE: The purpose of our study is to report our experience with the use of an ethylene vinyl alcohol copolymer (Onyx) in an off-label fashion for the treatment of type II endoleak after endovascular repair of the thoracic (TEVAR) and abdominal (EVAR) aorta. METHODS: A retrospective review of patients with type I and/or II endoleak treated with Onyx was performed. Data regarding the technical, clinical, and imaging outcomes were collected. Technical success was defined as decreased or eliminated endoleak on the first imaging follow-up. Clinical success was defined as unchanged or decreased aneurysm sac size on subsequent follow-up. RESULTS: Eighteen patients (15 male, 3 female) with a mean age of 79 years (range 69-92) met inclusion criteria (16 abdominal aortic aneurysm, 2 thoracic aortic aneurysm). Sixteen patients had type II endoleak, and 2 had complex type II endoleak with a type I component. The interval between endograft placement and treatment was a mean of 30 months. Direct sac treatment approach was used in 13 patients; transarterial approach was used in 3 patients. Seven patients required the use of coils, N-butyl cyanoacrylate glue, or Amplatzer vascular plugs. The average volume of Onyx used per treatment was 5.6 mL (range 2.5-13). Duration of imaging follow-up was 0.75-72.5 months (mean 32.8). Sixteen of 18 (88.9 %) patients had initial technical and clinical success. Two of 18 patients (11.1 %) were initial technical failures, and 1 remained a failure despite a second treatment and attempted surgical ligation. Eight of 18 (44.4 %) of patients eventually required a second intervention, 5 (27.8 %) of them due to delayed clinical failure. Complications included 1 psoas hematoma, 1 transient L2 nerve paresis, and 1 intraperitoneal Onyx leak; all of these were without clinical sequelae. CONCLUSION: Onyx with or without coil/glue/Amplatzer plug embolization is safe and useful in the treatment of type II endoleak after TEVAR and EVAR. However, long-term clinical and imaging follow-up is needed for early detection and management of recurrence of the primary endoleak or the development of new, secondary endoleaks or enlargement of the aneurysm sac.
Assuntos
Aneurisma da Aorta Abdominal/cirurgia , Aneurisma da Aorta Torácica/cirurgia , Dimetil Sulfóxido/uso terapêutico , Endoleak/terapia , Procedimentos Endovasculares , Uso Off-Label , Polivinil/uso terapêutico , Retratamento , Idoso , Idoso de 80 Anos ou mais , Cianoacrilatos/uso terapêutico , Embolização Terapêutica/métodos , Feminino , Humanos , Ligadura , Masculino , Estudos Retrospectivos , Dispositivo para Oclusão Septal , Resultado do TratamentoRESUMO
Subintimal recanalization can be a useful procedure in selected patients with severe peripheral vascular disease with tissue loss or rest pain and limited surgical bypass options. Technical failure occurs in approximately 20% of patient who undergo percutaneous intentional extraluminal recanalization due to inability to reenter the distal true lumen. A technique to improve technical success when performing subintimal recanalization when there is failure to reenter the distal true lumen or possibly when there is a limited segment of patent distal target vessel for reentry is proposed. Further evaluation of this technique is necessary to confirm its safety and determine its technical and clinical success.